ClinicalTrials.govpublic full text
Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer
breast cancer, invasive breast cancer, aromatase inhibitor, estrogen receptor, progesterone receptor, endocrine-targeted therapy, anti-estrogen therapy, hr+, her2-negative, neoadjuvant treatment, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 824836
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.